Literature DB >> 22489821

NDRG4 is downregulated in glioblastoma and inhibits cell proliferation.

Wenchao Ding1, Jing Zhang, Jae-Geun Yoon, Dongyan Shi, Gregory Foltz, Biaoyang Lin.   

Abstract

NDRG4 is a member of the N-myc downregulated gene family (NDRG) belonging to the alpha/beta hydrolase superfamily. We have previously documented discrepancy between our analysis of the expression and function of NDRG4 in glioblastoma multiforme (GBM) and a recent publication by Schilling et al., who reported that NDRG4 is upregulated in GBM compared to human cortex tissues and knock down of NDRG4 reduced the viability of GBM cells. In the present study, we found that NDRG4 is indeed downregulated, at both RNA and protein levels, by quantitative RT-PCR and Western blot analysis, in GBM compared to normal tissues, and that over expression of NDRG4 inhibited proliferation of GBM cells. These new observations can inform the selection of lead molecular compounds for drug discovery as well as novel diagnostics for GBM. They also lend evidence to NDRG4 a role of tumor suppressor.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22489821      PMCID: PMC3339384          DOI: 10.1089/omi.2011.0146

Source DB:  PubMed          Journal:  OMICS        ISSN: 1536-2310


  19 in total

1.  Characterization of the human NDRG gene family: a newly identified member, NDRG4, is specifically expressed in brain and heart.

Authors:  R H Zhou; K Kokame; Y Tsukamoto; C Yutani; H Kato; T Miyata
Journal:  Genomics       Date:  2001-04-01       Impact factor: 5.736

2.  From PTEN loss of expression to RICTOR role in smooth muscle differentiation: complex involvement of the mTOR pathway in leiomyosarcomas and pleomorphic sarcomas.

Authors:  Laure Gibault; Céline Ferreira; Gaëlle Pérot; Anne Audebourg; Frédéric Chibon; Sarah Bonnin; Pauline Lagarde; Marie-Cécile Vacher-Lavenu; Philippe Terrier; Jean-Michel Coindre; Alain Aurias
Journal:  Mod Pathol       Date:  2011-11-11       Impact factor: 7.842

3.  NDRG4 is required for cell cycle progression and survival in glioblastoma cells.

Authors:  Stephen H Schilling; Anita B Hjelmeland; Daniel R Radiloff; Irwin M Liu; Timothy P Wakeman; Jeffrey R Fielhauer; Erika H Foster; Justin D Lathia; Jeremy N Rich; Xiao-Fan Wang; Michael B Datto
Journal:  J Biol Chem       Date:  2009-07-10       Impact factor: 5.157

4.  NDRG1/2 expression is inhibited in primary acute myeloid leukemia.

Authors:  Mario P Tschan; Deborah Shan; Judith Laedrach; Marianne Eyholzer; Elisabeth Oppliger Leibundgut; Gabriela M Baerlocher; Andreas Tobler; Deborah Stroka; Martin F Fey
Journal:  Leuk Res       Date:  2009-09-22       Impact factor: 3.156

5.  Evaluation of NDRG2 gene expression in primary papillary thyroid carcinoma and in metastases of this neoplasm to regional lymph nodes.

Authors:  Anna Mordalska; Joanna Latek; Tomasz Ferenc; Lech Pomorski; Elzbieta Gałecka; Arkadiusz Zygmunt; Andrzej Lewiński
Journal:  Thyroid Res       Date:  2010-08-30

6.  Biological significance of aminopeptidase N/CD13 in thyroid carcinomas.

Authors:  Astrid Kehlen; Uwe Lendeckel; Henning Dralle; Jürgen Langner; Cuong Hoang-Vu
Journal:  Cancer Res       Date:  2003-12-01       Impact factor: 12.701

7.  N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer.

Authors:  Veerle Melotte; Marjolein H F M Lentjes; Sandra M van den Bosch; Debby M E I Hellebrekers; Joep P J de Hoon; Kim A D Wouters; Kathleen L J Daenen; Iris E J M Partouns-Hendriks; Filip Stessels; Joost Louwagie; Kim M Smits; Matty P Weijenberg; Silvia Sanduleanu; Carolina A J Khalid-de Bakker; Frank A Oort; Gerrit A Meijer; Daisy M A E Jonkers; James G Herman; Adriaan P de Bruïne; Manon van Engeland
Journal:  J Natl Cancer Inst       Date:  2009-06-17       Impact factor: 13.506

8.  Immunohistochemical detection of Ndrg2 in the mouse nervous system.

Authors:  Lan Shen; Zhen-Yu Zhao; Ya-Zhou Wang; Shao-Ping Ji; Xin-Ping Liu; Xue-Wu Liu; Hong-Lei Che; Wei Lin; Xia Li; Jian Zhang; Li-Bo Yao
Journal:  Neuroreport       Date:  2008-06-11       Impact factor: 1.837

9.  Suppression of N-myc downstream-regulated gene 2 is associated with induction of Myc in colorectal cancer and correlates closely with differentiation.

Authors:  Hai Shi; Haifeng Jin; Dake Chu; Weizhong Wang; Jian Zhang; Changsheng Chen; Chunsheng Xu; Daiming Fan; Libo Yao
Journal:  Biol Pharm Bull       Date:  2009-06       Impact factor: 2.233

10.  Crystal structure of the human N-Myc downstream-regulated gene 2 protein provides insight into its role as a tumor suppressor.

Authors:  Jungwon Hwang; Yoonjeong Kim; Ho Bum Kang; Lukasz Jaroszewski; Ashley M Deacon; Hwiseop Lee; Won-Chan Choi; Kyung-Jin Kim; Cheol-Hee Kim; Beom Sik Kang; Jie-Oh Lee; Tae-Kwang Oh; Jae Wha Kim; Ian A Wilson; Myung Hee Kim
Journal:  J Biol Chem       Date:  2011-01-18       Impact factor: 5.157

View more
  12 in total

1.  Autocrine VEGF maintains endothelial survival through regulation of metabolism and autophagy.

Authors:  Courtney K Domigan; Carmen M Warren; Vaspour Antanesian; Katharina Happel; Safiyyah Ziyad; Sunyoung Lee; Abigail Krall; Lewei Duan; Antoni X Torres-Collado; Lawrence W Castellani; David Elashoff; Heather R Christofk; Alexander M van der Bliek; Michael Potente; M Luisa Iruela-Arispe
Journal:  J Cell Sci       Date:  2015-05-08       Impact factor: 5.285

2.  6-gene promoter methylation assay is potentially applicable for prostate cancer clinical staging based on urine collection following prostatic massage.

Authors:  Kostyantyn A Nekrasov; Mark V Vikarchuk; Evgeniya E Rudenko; Igor V Ivanitskiy; Viacheslav M Grygorenko; Rostyslav O Danylets; Alexander G Kondratov; Liubov A Stoliar; Bizhan R Sharopov; Volodymyr I Kashuba
Journal:  Oncol Lett       Date:  2019-10-29       Impact factor: 2.967

3.  NDRG4, a novel candidate tumor suppressor, is a predictor of overall survival of colorectal cancer patients.

Authors:  Dake Chu; Zixi Zhang; Yi Zhou; Yunming Li; Shaojun Zhu; Jian Zhang; Qingchuan Zhao; Gang Ji; Weizhong Wang; Jianyong Zheng
Journal:  Oncotarget       Date:  2015-04-10

4.  Quantitative detection of methylated NDRG4 gene as a candidate biomarker for diagnosis of colorectal cancer.

Authors:  Wenhua Xiao; Huixia Zhao; Weiwei Dong; Quiwen Li; Jianhua Zhu; Guanghui Li; Shufang Zhang; Ming Ye
Journal:  Oncol Lett       Date:  2014-12-19       Impact factor: 2.967

5.  NDRG4 stratifies the prognostic value of body mass index in colorectal cancer.

Authors:  Jianyong Zheng; Yunming Li; Shaojun Zhu; Jipeng Li; Qingchuan Zhao; Gang Ji; Weizhong Wang; Dake Chu
Journal:  Oncotarget       Date:  2016-01-12

6.  NDRG4 is a novel oncogenic protein and p53 associated regulator of apoptosis in malignant meningioma cells.

Authors:  Rama P Kotipatruni; Xuan Ren; Dinesh Thotala; Jerry J Jaboin
Journal:  Oncotarget       Date:  2015-07-10

7.  NDRG4 promotes myogenesis via Akt/CREB activation.

Authors:  Mingfei Zhu; Rong Zheng; Yiwen Guo; Yunxia Zhang; Bo Zuo
Journal:  Oncotarget       Date:  2017-10-06

8.  NDRG4 hypermethylation is a potential biomarker for diagnosis and prognosis of gastric cancer in Chinese population.

Authors:  Xiaoying Chen; Yong Yang; Jing Liu; Bin Li; Yan Xu; Cong Li; Qi Xu; Guili Liu; Yingmin Chen; Jieer Ying; Shiwei Duan
Journal:  Oncotarget       Date:  2017-01-31

Review 9.  Nervous NDRGs: the N-myc downstream-regulated gene family in the central and peripheral nervous system.

Authors:  Simone L Schonkeren; Maartje Massen; Raisa van der Horst; Alexander Koch; Nathalie Vaes; Veerle Melotte
Journal:  Neurogenetics       Date:  2019-09-04       Impact factor: 2.660

Review 10.  Potential role of the N-MYC downstream-regulated gene family in reprogramming cancer metabolism under hypoxia.

Authors:  Ga Young Lee; Yang-Sook Chun; Hyun-Woo Shin; Jong-Wan Park
Journal:  Oncotarget       Date:  2016-08-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.